FDA Releases Final Guidance on Benefit-Risk Assessment for New Drug and Biological Products

Summary

The FDA has released a final guidance document to provide clarity on how to assess a drug's benefits and risks in new drug applications and biologics license applications, in accordance with the Prescription Drug User Fee Act and the 21st Century Cures Act.